BOEING CO/THE (BA) Fundamental Analysis & Valuation

NYSE:BA • US0970231058

Current stock price

198.41 USD
+3.29 (+1.69%)
At close:
198.85 USD
+0.44 (+0.22%)
After Hours:

This BA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. BA Profitability Analysis

1.1 Basic Checks

  • In the past year BA has reported negative net income.
  • BA had a positive operating cash flow in the past year.
  • BA had negative earnings in 4 of the past 5 years.
  • In multiple years BA reported negative operating cash flow during the last 5 years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B -10B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.12%, BA is in line with its industry, outperforming 44.30% of the companies in the same industry.
  • BA's Return On Equity of 34.65% is amongst the best of the industry. BA outperforms 93.67% of its industry peers.
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROIC N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • BA has a Profit Margin (2.11%) which is in line with its industry peers.
  • Looking at the Gross Margin, with a value of 4.79%, BA is doing worse than 84.81% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BA has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 2.11%
GM 4.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. BA Health Analysis

2.1 Basic Checks

  • BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for BA has been increased compared to 1 year ago.
  • Compared to 5 years ago, BA has more shares outstanding
  • The debt/assets ratio for BA has been reduced compared to a year ago.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50B 100B 150B

2.2 Solvency

  • Based on the Altman-Z score of 1.28, we must say that BA is in the distress zone and has some risk of bankruptcy.
  • BA has a worse Altman-Z score (1.28) than 81.01% of its industry peers.
  • A Debt/Equity ratio of 8.37 is on the high side and indicates that BA has dependencies on debt financing.
  • BA's Debt to Equity ratio of 8.37 is on the low side compared to the rest of the industry. BA is outperformed by 83.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Altman-Z 1.28
ROIC/WACCN/A
WACC9.96%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20B 40B 60B

2.3 Liquidity

  • BA has a Current Ratio of 1.19. This is a normal value and indicates that BA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BA (1.19) is worse than 79.75% of its industry peers.
  • BA has a Quick Ratio of 1.19. This is a bad value and indicates that BA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BA's Quick ratio of 0.40 is on the low side compared to the rest of the industry. BA is outperformed by 92.41% of its industry peers.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.4
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. BA Growth Analysis

3.1 Past

  • BA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 49.34%, which is quite impressive.
  • Looking at the last year, BA shows a very strong growth in Revenue. The Revenue has grown by 34.50%.
  • BA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.81% yearly.
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%

3.2 Future

  • The Earnings Per Share is expected to grow by 26.39% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 9.67% on average over the next years. This is quite good.
EPS Next Y103.37%
EPS Next 2Y56.63%
EPS Next 3Y41.46%
EPS Next 5Y26.39%
Revenue Next Year10%
Revenue Next 2Y12.26%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 10 -10 -20

More info and screens

Find the best growth stocksShow best growing peers

1

4. BA Valuation Analysis

4.1 Price/Earnings Ratio

  • BA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Based on the Price/Forward Earnings ratio of 571.27, the valuation of BA can be described as expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BA indicates a slightly more expensive valuation: BA is more expensive than 62.03% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, BA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 571.27
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BA does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as BA's earnings are expected to grow with 41.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y56.63%
EPS Next 3Y41.46%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BA Dividend Analysis

5.1 Amount

  • No dividends for BA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BA Fundamentals: All Metrics, Ratios and Statistics

BOEING CO/THE

NYSE:BA (3/23/2026, 8:04:00 PM)

After market: 198.85 +0.44 (+0.22%)

198.41

+3.29 (+1.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-27
Earnings (Next)04-21
Inst Owners73.74%
Inst Owner Change2.38%
Ins Owners0.04%
Ins Owner Change5.1%
Market Cap155.92B
Revenue(TTM)89.46B
Net Income(TTM)1.89B
Analysts83.24
Price Target277.93 (40.08%)
Short Float %1.48%
Short Ratio1.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.43
Dividend Growth(5Y)-36.84%
DP17.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-118.5%
Min EPS beat(2)-179.06%
Max EPS beat(2)-57.93%
EPS beat(4)2
Avg EPS beat(4)-38.78%
Min EPS beat(4)-179.06%
Max EPS beat(4)63.2%
EPS beat(8)4
Avg EPS beat(8)-30.95%
EPS beat(12)6
Avg EPS beat(12)-17.74%
EPS beat(16)6
Avg EPS beat(16)-664.18%
Revenue beat(2)2
Avg Revenue beat(2)2.86%
Min Revenue beat(2)2.82%
Max Revenue beat(2)2.89%
Revenue beat(4)3
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-2.69%
Max Revenue beat(4)2.89%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)5
Avg Revenue beat(12)-0.94%
Revenue beat(16)5
Avg Revenue beat(16)-3.25%
PT rev (1m)0.64%
PT rev (3m)8.17%
EPS NQ rev (1m)5.4%
EPS NQ rev (3m)-1393.94%
EPS NY rev (1m)71.8%
EPS NY rev (3m)-82.57%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-1.87%
Revenue NY rev (1m)0.55%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 571.27
P/S 1.74
P/FCF N/A
P/OCF 146.4
P/B 28.59
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-10.32
EYN/A
EPS(NY)0.35
Fwd EY0.18%
FCF(TTM)-2.4
FCFYN/A
OCF(TTM)1.36
OCFY0.68%
SpS113.84
BVpS6.94
TBVpS-17.04
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 1.12%
ROE 34.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 2.11%
GM 4.79%
FCFM N/A
ROA(3y)-2.7%
ROA(5y)-2.95%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.29%
GM growth 5YN/A
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 8.37
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 151.1%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.4
Altman-Z 1.28
F-Score6
WACC9.96%
ROIC/WACCN/A
Cap/Depr(3y)119.8%
Cap/Depr(5y)93.37%
Cap/Sales(3y)2.92%
Cap/Sales(5y)2.43%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)49.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.02%
EPS Next Y103.37%
EPS Next 2Y56.63%
EPS Next 3Y41.46%
EPS Next 5Y26.39%
Revenue 1Y (TTM)34.5%
Revenue growth 3Y10.33%
Revenue growth 5Y8.81%
Sales Q2Q%57.12%
Revenue Next Year10%
Revenue Next 2Y12.26%
Revenue Next 3Y11.43%
Revenue Next 5Y9.67%
EBIT growth 1Y49.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year226.52%
EBIT Next 3Y75.47%
EBIT Next 5Y46.89%
FCF growth 1Y86.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y108.82%
OCF growth 3Y-32.82%
OCF growth 5YN/A

BOEING CO/THE / BA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BOEING CO/THE (BA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BA.


What is the valuation status for BA stock?

ChartMill assigns a valuation rating of 1 / 10 to BOEING CO/THE (BA). This can be considered as Overvalued.


Can you provide the profitability details for BOEING CO/THE?

BOEING CO/THE (BA) has a profitability rating of 2 / 10.


Is the dividend of BOEING CO/THE sustainable?

The dividend rating of BOEING CO/THE (BA) is 0 / 10 and the dividend payout ratio is 17.51%.